These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 8106165)

  • 1. Carvedilol in heart failure.
    Kelly DT
    Cardiology; 1993; 82 Suppl 3():45-9. PubMed ID: 8106165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB
    Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.
    Krum H; Sackner-Bernstein JD; Goldsmith RL; Kukin ML; Schwartz B; Penn J; Medina N; Yushak M; Horn E; Katz SD
    Circulation; 1995 Sep; 92(6):1499-506. PubMed ID: 7664433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute hemodynamic effects of the vasodilator beta blocker carvedilol in heart failure].
    Buchwald A; Unterberg C; van der Does R; Wiegand V
    Z Kardiol; 1990 Jun; 79(6):424-8. PubMed ID: 1974100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New milestones in the therapy of chronic heart failure with beta blockers].
    Garlichs C; Daniel WG
    Z Kardiol; 2000 Mar; 89(3):236-8. PubMed ID: 10798280
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure.
    Palazzuoli A; Carrera A; Calabria P; Puccetti L; Pastrorelli M; Pasqui AL; Auteri A; Bruni F
    Am Heart J; 2004 Jan; 147(1):E2. PubMed ID: 14691440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
    Skudicky D; Bergemann A; Sliwa K; Candy G; Sareli P
    Circulation; 2001 Feb; 103(8):1083-8. PubMed ID: 11222470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
    Ruffolo RR; Feuerstein GZ
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study.
    Huang M; Zhang X; Chen S; Sun Y; Xiao Y; Sun J; Huang M; Chen S; Liu F
    Pediatr Cardiol; 2013 Mar; 34(3):680-5. PubMed ID: 23108482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.
    Feuerstein G; Ruffolo RR
    Adv Pharmacol; 1998; 42():611-5. PubMed ID: 9327976
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasodilating beta-blockers in heart failure.
    Raftery EB
    Eur Heart J; 1995 Jul; 16 Suppl F():32-7. PubMed ID: 8521882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.
    Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH
    N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long term use of a non-selective beta-blocker with vasodilating properties carvedilol in patients with severe heart failure].
    Zaikin SY; Iosava IK; Vasechkin SS; Gruzdev AK; Sidorenko BA
    Kardiologiia; 2002; 42(4):33-6. PubMed ID: 12494164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.
    Metra M; Nardi M; Giubbini R; Dei Cas L
    J Am Coll Cardiol; 1994 Dec; 24(7):1678-87. PubMed ID: 7963115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slowing the progression of heart failure.
    Cohn JN
    Eur Heart J; 1996 Nov; 17(11):1609-11. PubMed ID: 8922902
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure EvaluatioN trial (CARMEN)--rationale and design.
    Remme WJ;
    Cardiovasc Drugs Ther; 2001 Jan; 15(1):69-77. PubMed ID: 11504166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.